DIPG-16. COMBINATION OF ARGININE DEPLETION AND POLYAMINE INHIBITION AS AN ANTICANCER STRATEGY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)

Por Khan, Aaminah, Gamble, Laura, Pandher, Ruby, Burns, Mark R, Mussai, Francis, Norris, Murray, Haber, Michelle, Tsoli, Maria, Ziegler, David S
Publicado no Neuro Oncol (2020)

DIPG-15. POLYAMINE PATHWAY INHIBITION IS A POTENT NOVEL THERAPEUTIC STRATEGY AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA

Por Khan, Aaminah, Gamble, Laura, Upton, Dannielle, Yu, Denise, Ehteda, Anahid, Pandher, Ruby, Mayoh, Chelsea, Burns, Mark, Norris, Murray, Haber, Michelle, Tsoli, Maria, Ziegler, David
Publicado no Neuro Oncol (2020)

RARE-02. POLYAMINE PATHWAY INHIBITION IS A POTENT NOVEL THERAPEUTIC STRATEGY AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA

Por Khan, Aaminah, Gamble, Laura, Upton, Dannielle, Yu, Denise, Pandher, Ruby, Mayoh, Chelsea, Burns, Mark R, Norris, Murray D, Haber, Michelle, Tsoli, Maria, Ziegler, David S
Publicado no Neuro Oncol (2021)

Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas

Por Khan, Aaminah, Gamble, Laura D., Upton, Dannielle H., Ung, Caitlin, Yu, Denise M. T., Ehteda, Anahid, Pandher, Ruby, Mayoh, Chelsea, Hébert, Steven, Jabado, Nada, Kleinman, Claudia L., Burns, Mark R., Norris, Murray D., Haber, Michelle, Tsoli, Maria, Ziegler, David S.
Publicado no Nat Commun (2021)

DIPG-27. TARGETING FACILITATES CHROMATIN TRANSCRIPTION (FACT) AS A NOVEL STRATEGY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) THAT ENHANCES RESPONSE TO HISTONE DEACETYLASE (HDAC) I...

Por Ehteda, Anahid, Franshaw, Laura, Liu, Jie, Joshi, Swapna, Simon, Sandy, Pang, Chi Nam Ignatius, Giorgi, Federico, Pandher, Ruby, Ung, Caitlin, Tolhurst, Ornella, Mayoh, Chelsea, Khan, Aaminah, Hayden, Elisha, Gopalakrishnan, Anjana, Trebilcock, Peter, Upton, Dannielle, Lehmann, Rebecca, George, Sandra, Vittorio, Orazio, Tsoli, Maria, Gurova, Katerina, Gudkov, Andrei Gudkov, Norris, Murray D, Haber, Michelle, Ziegler, David S
Publicado no Neuro Oncol (2020)

HGG-09. TARGETING FACILITATES CHROMATIN TRANSCRIPTION (FACT) AS A NOVEL STRATEGY THAT ENHANCES RESPONSE TO HISTONE DEACETYLASE (HDAC) INHIBITION IN DIPG

Por Ehteda, Anahid, Simon, Sandy, Franshaw, Laura, Giorgi, Federico M, Liu, Jie, Hayden, Elisha, Rouaen, Jourdin, Pang, Chi Nam Ignatius, Pandher, Ruby, Mayoh, Chelsea, Tang, Yujie, Khan, Aaminah, Ung, Caitlin, Kankean, Anne, Lehmann, Rebecca, Shen, Sylvie, Gopalakrishnan, Anjana, Trebilcock, Peter, Gurova, Katerina, Gudkov, Andrei, Norris, Murray D, Haber, Michelle, Vittorio, Orazio, Tsoli, Maria, Ziegler, David S
Publicado no Neuro Oncol (2021)

A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction

Por Somers, Klaartje, Wen, Victoria W., Middlemiss, Shiloh M. C., Osborne, Brenna, Forgham, Helen, Jung, MoonSun, Karsa, Mawar, Clifton, Molly, Bongers, Angelika, Gao, Jixuan, Mayoh, Chelsea, Raoufi-Rad, Newsha, Kusnadi, Eric P., Hannan, Kate M., Scott, David A., Kwek, Alan, Liu, Bing, Flemming, Claudia, Chudakova, Daria A., Pandher, Ruby, Failes, Tim W., Lim, James, Angeli, Andrea, Osterman, Andrei L., Imamura, Toshihiko, Kees, Ursula R., Supuran, Claudiu T., Pearson, Richard B., Hannan, Ross D., Davis, Thomas P., McCarroll, Joshua, Kavallaris, Maria, Turner, Nigel, Gudkov, Andrei V., Haber, Michelle, Norris, Murray D., Henderson, Michelle J.
Publicado no Oncogene (2019)